Emerging Wegovy Vision-Loss Lawsuits Consolidated in New Jersey and in Federal Court In 2025, the New Jersey Supreme Court consolidated Wegovy lawsuits involving NAION complications in an MCL with other lawsuits regarding GLP-1 drugs and vision loss
[84] Type 1 narcolepsy results from the loss of approximately 70,000 orexin-releasing neurons in the lateral hypothalamus, leading to significantly reduced cerebrospinal orexin levels
History of gastrointestinal disorders (e.g., gastroparesis or inflammatory bowel disease), as semaglutide may slow gastric emptying and worsen these diseases
If you take too much by mistake, it can cause side effects
The risk of kidney cancer was 38% higher among patients taking GLP-1 drugs, though larger studies are needed to confirm its significance
Someone with robust mitochondrial function can ramp up ATP production to meet increased demand